5 Things You Didn’t Know About Medpace’s Biorepository Services
March 30, 2021
Medpace Biorepository, a CAP accredited facility, is a key component of Medpace Central Labs and the full-service model.
Read More
Central Laboratories
Central Laboratories
Medpace Bolsters In-House Central Lab Expertise with the Addition of Three New Scientists
December 22, 2020
Medpace is pleased to announce the addition of three scientists to our Central Laboratory leadership team.
Read More
Central Laboratories
The First Controlled Clinical Trial For A CRISPR Enhanced Bacteriophage Therapy
August 24, 2020
In a recent article published in Clinical Leader, Ed Miseta, Chief Editor highlights Medpace’s partnership with Locus Biosciences and their development of crPhage™, a bacteriophage that have been engineered to deliver the CRISPR-Cas3 constructs into the target bacteria.
Read More
Central Laboratories
China Central Lab Expansion
May 20, 2020
As part of our efforts to expand laboratory services and capabilities, specifically in Asia, Medpace has relocated our central laboratory facilities from Beijing to Shanghai. The Shanghai lab is a larger laboratory (with a 180% increase in space) and has allowed Medpace to expand capabilities to better service our client’s clinical trials in China.
Read More
Central Laboratories
Ask an Expert: Understanding Regulation and Validation Processes for Biomarkers
April 28, 2020
We sat down with Christopher Daniels, Director, Clinical Laboratory Services at Medpace, to discuss regulations and standards for biomarkers, validation process for central labs, and the benefit of working with an experienced partner.
Read More
Central Laboratories
Minimizing Disruption to Clinical Trials During COVID-19
April 16, 2020
Medpace is committed to keeping Sponsors on PACE to maintain regular activity during this irregular time.
Read More
Central Laboratories
Biorepository Risk Mitigation Plan: The Value of Specimen Storage for Clinical Research
April 8, 2020
In a process-oriented industry that breathes deeply from a standard set of regulations, it is easy to see the importance of each storage unit in the repository and the value of a biorepository risk mitigation plan.
Read More
Central Laboratories
COVID-19 Laboratory Testing: Medpace Central Labs
April 6, 2020
To serve our Sponsors in their COVID-19 programs, Medpace has expedited COVID-19 assay validations to meet clinical trial testing standards.
Read More
Central Laboratories
Belgium Central Lab Expansion
January 3, 2020
As part of our efforts to expand laboratory services and capabilities, Medpace’s central lab in Belgium recently completed extensive expansions including a new modern laboratory building at the Leuven facility. Highlights include an expanded onsite PhD Team, new molecular suite, flow cytometry services grow, biorepository updates, and logistics/kit building expansion
Read More
Central Laboratories
The Current Biomarker Landscape in Immuno-Oncology
June 13, 2019
Dr. El Mustapha Bahassi, Associate Director of Clinical Laboratories at Medpace, highlights the biomarker landscape in immuno-oncology clinical research.
Read More